The relationship between Johns Hopkins and clinical trials dates back 1986, and almost all major therapeutic approaches for ALS have been carried out, or initiated, at Johns Hopkins including (partial list): neuroimmunomodulation, anti-excitotoxic, antioxidant, energy metabolism, protein aggregation, and growth factor based therapies.
Glial progenitor-derived astrocyte and neuron coculture
If you, a family member, or loved one are interested in finding out about any clinical trials focused on Amyotrophic Lateral Sclerosis (ALS), learn more at www.clinicaltrials.gov, a registry and results database of federally and privately supported clinical trials conducted in the U.S. and around the world.
To learn more about the Ansari ALS Center, please call 443-287-4341.
To learn more about our current clinical trials, call The Johns Hopkins ALS Clinic at 410-955-8511.
Request an appointment
To make an appointment with one of our specialists at the ALS Clinic, call 410-955-8511.